# The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar.

> **NCT02973659** · NA · COMPLETED · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 61 (actual)

## Conditions studied

- Hyperhidrosis

## Interventions

- **DRUG:** Oxybutynin
- **DRUG:** Placebos

## Key facts

- **NCT ID:** NCT02973659
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2016-08
- **Final completion:** 2016-10
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2016-11-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02973659

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02973659, "The Use of Topical Oxybutynin 10% for Treating Primary Focal Hyperhidrosis-axillary, Palmar and Plantar.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02973659. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*